Genocea Biosciences
GNCA
#10614
Rank
S$0 M
Marketcap
S$0.0001296
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)

Revenue for Genocea Biosciences (GNCA)

Revenue in 2022 (TTM): S$2.59 Million

According to Genocea Biosciences 's latest financial reports the company's current revenue (TTM ) is S$2.47 Million. In 2021 the company made a revenue of S$2.21 Million an increase over the revenue in the year 2020 that were of S$1.79 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Genocea Biosciences from 2013 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) S$2.59 M16.95%
2021 S$2.21 M23.39%
2020 S$1.79 M
2019 N/A
2018 N/A
2017 N/A-100%
2016 S$0.34 M-64.11%
2015 S$0.94 M132.87%
2014 S$0.4 M-56.06%
2013 S$0.92 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Agenus
AGEN
S$0.13 B 5,490.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$1.32 B 53,501.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$83.24 B 3,361,229.15%๐Ÿ‡บ๐Ÿ‡ธ USA
iBio
IBIO
S$0.51 M-79.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$81.36 B 3,285,404.97%๐Ÿ‡บ๐Ÿ‡ธ USA